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Introduction
The Deepwater Horizon (DWH) oil spill, 
which began 20 April 2010, resulted in the 
release of > 200 million gallons of MC252 
(Mississippi Canyon block 252) crude oil 
into the Gulf of Mexico. Approximately 
2 million gallons of dispersant was used to 
emulsify the oil into the water column, with 
the aim of aiding in oil biodegradation and 
preventing the oil from reaching fragile near-
shore habitats (Kujawinski et al. 2011). The 
dispersant applied by aerial spray and at the 
wellhead oil source was primarily COREXIT 
9500 (EC9500, EC9500A, and EC9500B) 
and secondarily COREXIT 9527 (Nalco 
Environmental Solutions). Dispersant has 
been shown to increase the bioavailability 
of oil components, such as polycyclic 
aromatic hydrocarbons (PAHs) to fishes 
(Ramachandran et al. 2004). Although many 
studies in a variety of animal models have 
focused on the toxicity of crude oil, dispersed 
oil, or dispersant alone (Almeda et al. 2013; 
Hemmer et al. 2011; Rico-Martínez et al. 
2013), long-term sub-lethal studies are limited.
Both oil and dispersant are implicated as 
potential endocrine and metabolic disruptors. 
Crude oil is linked to reproductive effects in 
male rats (Adedara et al. 2014), and disper-
sants have been shown to be estrogenic in an 
in vitro transactivation assay using a human 
liver hepatoma cell line (Judson et al. 2010). 
Also, maternal exposure to PAHs (major 
components of oil) in ambient air during 
pregnancy was associated with a higher preva-
lence of obesity at 5 and 7 years of age among 
participants in a New York City birth cohort 
(Rundle et al. 2012). Given the massive 
quantity of oil released and the unprecedented 
use of dispersant during the DWH oil spill, it 
is important to understand potential impacts 
to human health through direct and indirect 
exposures including those resulting from relief 
efforts and seafood consumption, respectively.
Obesity is a major health problem that 
contributes to a variety of diseases, including 
type II diabetes, hypertension, and cancer 
(Calle 2007; Ogden et al. 2006). Although 
traditionally attributed solely to an imbal-
ance in energy intake versus expenditure, 
recent evidence implicates environmental 
agents known as “obesogens” as potential 
contributors to the obesity epidemic, espe-
cially in children (Grün and Blumberg 
2006). The mechanism of action of obeso-
gens is not completely understood, but any 
chemical that affects food intake, energy 
expenditure, lipid metabolism, or adipocyte 
(fat cell) differentiation could potentially 
act as an obesogen. The master regulator of 
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Background: The obesity pandemic is associated with multiple major health concerns. In addition 
to diet and lifestyle, there is increasing evidence that environmental exposures to chemicals known 
as obesogens also may promote obesity.
oBjectives: We investigated the massive environmental contamination resulting from the 
Deepwater Horizon (DWH) oil spill, including the use of the oil dispersant COREXIT in reme-
diation efforts, to determine whether obesogens were released into the environment during this 
incident. We also sought to improve the sensitivity of obesogen detection methods in order to guide 
post-toxicological chemical assessments.
Methods: Peroxisome proliferator–activated receptor gamma (PPARγ) transactivation assays were 
used to identify putative obesogens. Solid-phase extraction (SPE) was used to sub-fractionate the 
water-accommodated fraction generated by mixing COREXIT, cell culture media, and DWH oil 
(CWAF). Liquid chromatography–mass spectrometry (LC-MS) was used to identify components 
of fractionated CWAF. PPAR response element (PPRE) activity was measured in PPRE-luciferase 
transgenic mice. Ligand-binding assays were used to quantitate ligand affinity. Murine 3T3-L1 
preadipocytes were used to assess adipogenic induction.
results: Serum-free conditions greatly enhanced the sensitivity of PPARγ transactivation assays. 
CWAF and COREXIT had significant dose-dependent PPARγ transactivation activities. From SPE, 
the 50:50 water:ethanol volume fraction of CWAF contained this activity, and LC-MS indicated 
that major components of COREXIT contribute to PPARγ transactivation in the CWAF. Molecular 
modeling predicted several components of COREXIT might be PPARγ ligands. We classified dioctyl 
sodium sulfosuccinate (DOSS), a major component of COREXIT, as a probable obesogen by PPARγ 
transactivation assays, PPAR-driven luciferase induction in vivo, PPARγ binding assays (affinity 
comparable to pioglitazone and arachidonic acid), and in vitro murine adipocyte differentiation.
conclusions: We conclude that DOSS is a putative obesogen worthy of further study, including 
epidemiological and clinical investigations into laxative prescriptions consisting of DOSS.
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Bowden JA, Kucklick JR, Baatz JE, Spyropoulos DD. 2016. Effects of crude oil/dispersant mixture 
and dispersant components on PPARγ activity in vitro and in vivo: identification of dioctyl 
sodium sulfosuccinate (DOSS; CAS #577-11-7) as a probable obesogen. Environ Health Perspect 
124:112–119; http://dx.doi.org/10.1289/ehp.1409672
Obesogenic activity of DOSS
Environmental Health Perspectives • volume 124 | number 1 | January 2016 113
adipocyte differentiation, the nuclear receptor 
PPARγ (peroxisome proliferator–activated 
receptor gamma) (Janesick and Blumberg 
2011), is a prime target on which obesogens 
act. Obesogens include diethylstilbestrol 
(Newbold et al. 2005), bisphenol A (Somm 
et al. 2009), various phthalates and their 
metabolites (Stahlhut et al. 2007), fungicides 
and insecticides such as triflumizole (Li et al. 
2012), hydrocarbons (Tracey et al. 2013), 
and the marine anti-fouling agent tributyltin 
(Kirchner et al. 2010). It is therefore relevant 
to determine whether novel obesogens exist in 
oil or dispersants.
We investigated the obesogenic poten-
tial of COREXIT 9500–dispersed MC252 
crude oil and identified the major COREXIT 
component, dioctyl sodium sulfosuccinate 
(DOSS), as a likely obesogen. In addition to 
it being a major component of the dispersant 
COREXIT, DOSS is widely used in phar-
maceuticals and personal care products [U.S. 
Department of Health and Human Services 
(DHHS) 2014; Environmental Working 
Group (EWG) 2015a].
Materials and Methods
Transfection and PPARγ reporter gene 
assays. For PPARγ transactivation assays, 
HEK293T/17 cells (ATCC CRL-11268) 
were maintained in DMEM/F12 (Dulbecco’s 
Modified Eagle Medium: Nutrient Mixture 
F-12; Gibco by Life Technologies) containing 
10% fetal bovine serum (ThermoScientific), 
2 mM glutamax, 100 μM nonessential amino 
acids, and antibiotic/antimycotic. Cells 
were transfected with Lipofectamine 2000 
according to the manufacturer’s protocol 
(Invitrogen by Life Technologies) and plated 
in 96-well dishes at a density of 20,000 cells 
per well. Each well of cells was transfected 
with 16 ng PPARγ-Gal4 [fusion protein 
of the yeast GAL4 DNA-binding domain 
(amino acids 1-147) and the mouse PPARγ 
ligand-binding domain (a.a. 163–475); 
kindly provided by B. Blumberg, University 
of California, Irvine], 80 ng UASx4 TK-luc 
[contains four copies of the GAL4 upstream 
activating sequence and the herpes virus 
thymidine kinase promoter (–105/+51) 
driving firefly luciferase] and 4 ng of pRL 
vector (encoding Renilla luciferase to control 
for transfection efficiency). The next day, trip-
licate wells of cells were treated as described. 
Cell lysates were harvested after 18 hr of treat-
ment and the Dual-Luciferase Reporter Assay 
System (Promega) and a Veritas microplate 
luminometer (Turner Biosystems) were used 
to measure firefly and Renilla luminescence 
according to the manufacturers’ recommen-
dations. For assays using human PPARγ, 
PPARα, and PPARβ/δ plasmids were kindly 
provided by B. Abbott, U.S. Environmental 
Protection Agency, and are described by 
Bility et al. (2004). The GAL4-RXRα 
plasmid was kindly provided by B. Blumberg 
(Grün and Blumberg 2006).
Preparation of oil water-accommodated 
fractions. To distinguish PPARγ activity 
originating from the dispersant COREXIT 
9500 (Nalco Environmental Solutions LLC) 
from MC252 oil (AECOM), a suite of 
water-accommodated fractions (WAF) was 
prepared using alternative oils and solvents. All 
water-accommodated fraction mixtures were 
prepared by vigorously stirring the compo-
nents overnight followed by 12 hr of gravity 
separation and aqueous phase collection. 
CWAF (COREXIT water- accommodated 
fraction) is COREXIT 9500, MC252 oil, 
and DMEM/F12 cell culture media mixed 
1:20:200 (ratios by volume). WAF is 
MC252 oil and DMEM/F12 mixed 1:10. 
CMWAF (COREXIT Mazola corn oil water- 
accommodated fraction) is COREXIT, Mazola 
corn oil, and DMEM/F12 mixed 1:20:200. 
COREXIT only mixtures are COREXIT and 
DMEM/F12 mixed 1:200. DWAF (dimethyl 
sulfoxide water-accommodated fraction) is 
DMSO (dimethyl sulfoxide), MC252 oil, and 
DMEM/F12 mixed 2:20:200.
S o l i d - p h a s e  e x t r a c t i o n  ( S P E ) . 
Fractionation of CWAF was performed to 
determine if compounds from COREXIT 
or oil were responsible for the observed 
PPARγ activity. Bond Elut 3-mL silica solid 
phase columns (Agilent Technologies) and 
vacuum manifold chambers were employed 
to fractionate CWAF. Four fractions bearing 
differential polarities and hydrophobicities 
were collected in the following order: 50:50 
water:ethanol, methanol, dichloromethane, 
and hexanes. For every 75 μL of CWAF 
loaded into the column, 100 μL of water was 
used to pull the sample through the column, 
and 2 mL of solvent was used to collect each 
fraction. Before downstream applications 
solvents were removed by vaporization using 
a Savant ISS110 SpeedVac Concentrator 
(Thermo Scientific) and resuspended in 10 μL 
DMSO/500 μL of fraction.
Chemical  analysi s  of  CWAF sub-
fractions. Composition of the CWAF 
ethanol:water extractable SPE fraction was 
determined using a heated (50°C) Kinetex 
liquid chromatography (LC) C-18 column 
(100 mm × 2.1 mm, 1.7 μm; Phenomenex) 
on an Agilent 1100 LC with autosampler. 
The mobile phases were solvent A: milli-Q 
water with 1.0 M ammonium acetate 
(pH 6.5; Fisher Scientific) and 0.1% formic 
acid:water (volume fraction, 98%, ACS 
grade; EMD Millipore); and solvent B: 1:1 
(vol/vol) isopropanol (IPA):acetonitrile 
(ACN) (volume fraction, Scientific) with 
1.0 M ammonium acetate (pH 6.5) and 0.1% 
formic acid:IPA/ACN (volume fraction). 
The components of CWAF (5 μL injection) 
were separated using a flow rate of 200 μL/
min that started at 40% solvent A (for 5 min) 
and changed to 20% A (0 min to 5 min), 
to 0% A (5 min to 19 min), back to 40% 
A (19 min to 20 min), and equilibrated 
at 40% A for 5 min. Separated compo-
nents were detected using an AB Sciex API 
4000 triple quadrupole mass spectrometer 
(equipped with a TurboV electrospray ioniza-
tion source) operating with Analyst software 
(v. 1.5.2). Full-scan (FS) mass spectrometric 
(MS) experiments (scanning m/z 200–1,200) 
were performed in both positive and negative 
polarity mode to identify potential target 
masses in the ethanol/water fraction. The 
FS parameters (positive/negative) were scan 
rate (2 sec), entrance potential (10/–10 V), 
declustering potential (75/–75 V), curtain 
gas (20), gas 1 (20), gas 2 (20), ion spray 
voltage (5,000/–4,500 V), source temperature 
(500°C) and interface heater on. To further 
characterize the target masses, product ion 
scans (MS/MS) were collected [collisionally 
activated dissociation (4), collision energy 
(30 eV), cell exit potential (15 V)]. Upon 
identification of commonalities in the frag-
mentation of the target masses, precursor ion 
scans (PIS) of m/z 307.3, 309.3, and 311.3 
(corresponding to fragments of ethyl lino-
leate, ethyl oleate, and ethyl stearate, respec-
tively) were employed to highlight analyte 
classes that exhibited specific in-source fatty 
acid fragments commonly associated with 
polysorbate (Tween) materials (Hvattum 
et al. 2012). Noting the recently reported 
ingredients of COREXIT, tentative identifi-
cation of two dominant components of the 
CWAF ethanol/water extract, polysorbate 
80 (Tween 80) and DOSS, was made by 
comparing the acquired mass spectrometric 
data (MS, MS/MS, and PIS) to previously 
published reports (Chen et al. 2002; Hvattum 
et al. 2012; Mathew et al. 2012; Ramirez 
et al. 2013; Zhang et al. 2012).
To confirm the presence of Tween 80, 
the sub-fraction was analyzed in positive FS 
mode, revealing several unique mass profiles 
with mass differences (between adjacent ions) 
of 22 and 44 amu, reported to be [M + NH4]+ 
and [M + 2NH4]2+ ions of polysorbate species 
(Zhang et al. 2012). Product ion scans showed 
that the m/z 309.3 ion was the most frequent 
fragment for the target masses. Previous 
reports attributed the m/z 309 fragment ion 
to an in-source loss of specific fatty acid esters 
(ethyl oleate, for m/z 309.3) characteristic of 
polysorbate species (Hvattum et al. 2012), or 
more recently to a strong presence of oleate-
related species in polysorbate 80 (Tween 
80) (Zhang et al. 2012). PIS of m/z 309.3 
demonstrated several mass spectral profiles 
relating to sorbitan monooleates (specifi-
cally 16–27 polyoxyethylene units, as shown 
in Supplemental Material, Figure S2A), 
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isosorbide monooleates, and sorbitan diole-
ates, indicating the presence of Tween 80. 
The other highly abundant component of the 
CWAF ethanol/water sub-fraction was DOSS. 
Initial investigation of the extract in negative 
FS mode revealed an intense ion at m/z 421. A 
total ion chromatogram performed in negative 
FS mode is shown in Supplemental Material, 
Figure S2B, with the peak at 2.45 min largely 
representing the [M-H]– ion of DOSS. To 
confirm the presence of DOSS, a product ion 
scan of m/z 421.1 was performed, and the 
resultant fragmentation profile is shown in 
Supplemental Material, Figure S2B. Based on 
previous reports, which indicate the presence 
of fragment ions m/z 81 and m/z 227 (Mathew 
et al. 2012; Ramirez et al. 2013), it was 
confirmed that DOSS was abundantly present 
in the 50:50 ethanol:water sub-fraction.
Molecular modeling of COREXIT compo-
nents binding to the PPARγ ligand-binding 
domain. Molecular modeling was assessed 
using MOE software (Molecular Operating 
Environment; Chemical Computing Group, 
Inc.). Two PDB (Protein Data Bank; http://
www.wwpdb.org/) crystal structures, 4EMA 
and 2HFP, constituting the human PPARγ 
ligand-binding domain bound to different 
ligands, were compared. Using MOE’s 
superposition function, no significant differ-
ences were found in the active site of PPARγ 
[RMSD (root-mean-square deviation) < 2Å]. 
Because it contained our positive control 
Rosiglitazone (Rosi), 4EMA was chosen as 
the model. Ten compounds, including some 
metabolites, were docked to PPARγ. Molecular 
parameters were set for maximum energy 
minimization and Amber12 liquid state. Five 
compounds that constitute COREXIT, a 
negative control (17β-estradiol), and a positive 
control (Rosi) were assessed and virtually 
synthesized based on liquid state parameters at 
pH 7.4. The run was set to 30 different poses, 
with an area for 30 refinements if necessary. 
After parameters were set, a continuous run of 
all compounds were docked, and descriptors 
of binding data were given in ascending order 
related to E score. The E score gives binding 
efficiency in terms of energy state, with lower 
E scores indicating higher affinity. Compounds 
that had the capability to be cleaved by ester-
ases were assessed with and without the fatty 
acid chains.
In vivo  bioluminescence imaging . 
The “repTOP PPRE-Luc” mouse model 
[PPAR response element (PPRE)–lucif-
erase mouse], containing a PPAR response 
 element– luciferase reporter transgene (El-Jamal 
et al. 2013) was used for in vivo biolumines-
cence imaging. C57BL/6J mice (originally 
obtained from Charles River Laboratories) 
were bred in the animal facilities at the Medical 
University of South Carolina (MUSC). All 
mice were treated humanely and with regard 
to alleviation of suffering, according to the 
Guide for the Care and Use of Laboratory 
Animals (National Research Council 2011). 
Mice were housed up to five per cage in venti-
lated air racks with ad libitum access to water 
and irradiated rodent chow (Harlan 2018). 
Temperature was maintained between 21°C 
and 23°C, humidity maintained 40%, and 
a 12-hr light:dark cycle. Five groups of three 
male mice (littermates age 5–6 weeks) were 
injected i.p. (intraperitoneally) at 0900 hours 
in the animal housing facility with saline, 
10 mg/kg Rosi (Rosiglitazone; Cayman 
Chemical), or 50 mg/kg DOSS (Dioctyl 
sodium sulfosuccinate; Sigma Aldrich). Five 
hours later mice were anesthetized with 2.5% 
isofluorane (Sigma Aldrich) in air and injected 
i.p. with 150 mg/kg luciferin potassium salt 
(Goldbio). An IVIS 200 bioluminescence 
imaging system and Living image 4.3.1 
software were used to quantify biolumines-
cence according to the manufacturer’s instruc-
tions (Caliper Life Sciences). Specifically, mice 
were placed in the instrument and received 
2% isofluorane in air through nosecones to 
maintain sedation during image acquisition. 
PPRE-driven bioluminescence of live mice was 
quantified using images acquired 10 min after 
luciferin injection with 1-min exposures. While 
mice were still sedated, they were sacrificed by 
cervical dislocation, livers were dissected and 
washed in PBS and then homoge nized in lysis 
buffer, and luciferase activity was determined 
in liver homogenates using the Luciferase 
Reporter Assay System and a Veritas micro-
plate luminometer. All animal procedures were 
approved by the Institutional Animal Care 
& Use Committee, MUSC (Animal Welfare 
Assurance #A3428-01).
TR-FRET PPARγ competitive binding 
assay. Competitive time-resolved fluores-
cence resonance energy transfer (TR-FRET) 
(Toth et al. 2012) binding assays were used 
to determine the affinity of DOSS for PPARγ 
(SelectScreen Service; Life Technologies). For 
these assays the donor fluorophore (terbium) 
on the receptor causes energy transfer to the 
acceptor fluorophore (Fluormone Green) 
on the bound ligand, resulting in emission 
at 520 nM. With increasing doses of ligand 
(e.g., DOSS), there is increasing displace-
ment of receptor-bound Fluormone Green–
tagged positive control ligand and, hence, 
less signal. Known concentrations of test and 
control ligands allow fluorescent emission 
loss to be used to quantitate binding affinity. 
Terbium is excited with a 340-nm filter 
and emits multiple peaks, the first of which 
(485–505 nm) overlaps with the maximum 
excitation peak of Fluormone Green. To 
measure energy transfer to Fluormone 
Green without interference from terbium, a 
520/25-nm filter is used with a 100-μsec delay 
and 200-μsec integration.
Adipogenic differentiation assays. For tria-
cylglycerol staining assays to quantify adipo-
genic differentiation, 3T3-L1 preadipocyte 
cells (Zenbio) were plated in 48-well plates at 
a density of 10,000 cells per well in preadi-
pocyte growth medium (PGM; DMEM/F12 
supplemented as described above) and grown 
until confluence. Two days postconfluence, 
the media were changed to minimal induc-
tion media [MIM; PGM supplemented with 
62.5 nM dexamethasone, 0.125 mM IBMX 
(3-isobutyl-1-methylxanthine), and 250 
ng/mL insulin] and either different concen-
trations of DOSS (10, 20, 25, or 50 ppm) 
or 1 μM Rosi. After 72 hr of induction, the 
media was switched to PGM containing 
1 μg/mL insulin. Cells were allowed to differ-
entiate for 3 more days (6 days total) and fixed 
with 4% paraformaldehyde. Triacylglycerol 
staining with AdipoRed (Lonza) and nuclear 
counter-staining with NucBlue (Hoechst; 
Invitrogen) was conducting according to 
the manufacturers’ recommendations. 
Adipogenesis was quantified by mean relative 
fluorescent units of 42 fields per well (10× 
magnification) with five replicates used 
for each treatment using a HERMES high 
content screening scanner (WiScan; IDEA 
Bio-Medical Ltd.). Hoechst fluorescence was 
determined using excitation 390/18 nm and 
emission 440/40 nm (light intensity: 50%; 
exposure: 30 msec; gain: 30%), and AdipoRed 
was quantified using excitation 485/20 nm 
and emission 525/30 nm (light intensity: 
90%; exposure: 58 msec; gain: 30%).
mRNA expression via quantitative poly-
merase chain reaction (qPCR). 3T3-L1 cells 
were treated with test ligands as described 
above. After 72 hr of exposure to MIM 
supplemented with varying concentrations 
of DOSS or Rosi, three wells of treatment 
were pooled from each of two experiments 
for mRNA expression analyses. RNA was 
isolated using the RNeasy Kit (Qiagen), 
following the manufacturer’s instructions. 
Gene expression was assessed in triplicate 
using 25 ng of RNA per qPCR reaction and 
the iTaq Universal SYBR Green One-Step 
Kit following the manufacturer’s instruc-
tions (BioRad). Results were normalized 
to the housekeeping gene Hprt. Data are 
expressed as a fold change compared with the 
MIM-only control. Primer sequences for the 
queried genes can be found in Supplemental 
Material, Table S1.
Statistical analysis. All data analyses were 
performed using GraphPad Prism software 
(GraphPad Software Inc.). After confirma-
tion of normality and equal variance (using 
Brown–Forsythe and Bartlett tests), one-way 
analysis of variance (ANOVA) followed by 
Dunnett’s multiple comparisons post hoc 
tests were performed. p-Values < 0.05 were 
deemed significantly different.
Obesogenic activity of DOSS
Environmental Health Perspectives • volume 124 | number 1 | January 2016 115
Results
PPARγ ligand-binding assay optimization. 
We optimized a rapid, sensitive, specific, and 
robust system for detecting PPARγ transactiva-
tion activity in MC252 oil and COREXIT 
dispersant. Considering that COREXIT 
is a mixture of solvents and surfactants that 
might compromise membrane integrity and 
also that components of fetal bovine serum 
(FBS) may have PPARγ agonist activity that 
would obscure testing, we determined whether 
a PPARγ ligand-binding domain–GAL4–UAS 
luciferase system (Forman et al. 1995) could 
be conducted with cells under serum-free 
(SF) conditions. HEK293T/17 cells were 
transfected with plasmids encoding a yeast 
GAL4 DNA-binding domain–mouse PPARγ 
ligand-binding domain fusion protein, a yeast 
UAS (GAL4 upstream activator sequence) 
driving firefly luciferase, and a constitutively 
active Renilla luciferase transfection efficiency 
control. The PPARγ agonist Rosi confirmed 
the accuracy of the system for detecting PPARγ 
transactivation activity. As shown in Figure 1, 
treatment of transfected cells with 0, 10 nM, 
or 100 nM Rosi for 4 hr, 8 hr, or 18 hr 
resulted in time- and dose-dependent increases 
in luciferase activity in both serum-containing 
(10% FBS) and SF conditions. Notably, the 
response to Rosi under SF culture conditions 
was more pronounced than serum-containing 
cultures at all time points (Figure 1A–C). 
Conversely, treatment for 18 hr under SF 
conditions with 17β-estradiol (E2) or all-trans-
retinoic acid (RA) did not increase luciferase 
activity, whereas Rosi treatment induced 
marked luciferase activity (Figure 1D). These 
data demonstrate the sensitivity and specificity 
of the PPARγ ligand-binding domain–GAL4–
UAS luciferase system. SF conditions and 
18-hr treatments were chosen for subsequent 
experiments aimed at identifying compo-
nents of oil and COREXIT bearing PPARγ 
 transactivation activity.
PPARγ transactivation. To distinguish 
between PPARγ activity originating from 
dispersant and from MC252 oil, several 
mixtures of MC252 oil, with and without 
COREXIT, were prepared and analyzed for 
PPARγ transactivation activity, including 
CWAF, WAF, CMWAF, and COREXIT 
only (see “Materials and Methods”). Dose-
dependent PPARγ activation was detected in 
CWAF, CMWAF, and COREXIT dilutions 
but not in WAF (Figure 2). The CWAF and 
CMWAF fractions comprise the aqueous 
fraction of the original mixtures of oil and 
dispersant, and a portion of the amphipathic 
compounds present in the original mixtures 
was expected to partition to the organic 
phase. Also, the dose-dependent PPARγ 
activation by COREXIT alone (no organic 
phase) substantially outstripped those of 
CWAF and CMWAF; these results suggest 
that components of COREXIT were respon-
sible for the activity detected. To further 
investigate whether oil might have contrib-
uted to PPARγ activation by the fractions, an 
alternate solvent, DMSO, was used to prepare 
DWAF (DMSO water-accommodated 
fraction), which lacks COREXIT. Although 
twice the amount of DMSO was used to 
Figure 2. PPARγ transactivation by COREXIT. Dilutions of mixtures were prepared, HEK293T/17 cells trans-
fected and exposed in triplicate for 18 hr, and luciferase activities were measured. (A) CWAF, (B) WAF, 
(C) CMWAF. A–C are presented as final concentrations volume fractions. (D) COREXIT, diluted in cell 
culture media to the concentrations indicated volume fractions. Dose-dependent ligand binding activities 
were detected in CWAF, CMWAF, and COREXIT dilutions but not in WAF dilutions. RLU, relative light units.
Data are expressed as mean ± SD; n = 3 per group (*p < 0.05 vs. control).
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Figure 1. PPARγ transactivation activity in a GAL4-UAS system using serum-free conditions. HEK293T/17 
cells were transfected and exposed to the PPARγ agonist Rosi under serum-containing (10% FBS) and 
serum-free (SF) conditions in triplicate, and luciferase activities were measured following exposure for 
(A) 4 hr, (B) 8 hr, and (C) 18 hr. Data in A–C are normalized to the 10% FBS control within each time point. 
Assay sensitivity is greatly enhanced under SF conditions. (D) HEK293T/17 cells were transfected and 
exposed to estrogen (E2), all-trans-retinoic acid (RA), or Rosi under SF conditions, and luciferase activities 
were measured, demonstrating ligand-specific responsiveness of the system. Data in D are normalized to 
the untreated control. RLU, relative light units. Data are expressed as mean ± SD; n = 3 per group (*p < 0.05 
vs. control).
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prepare DWAF than COREXIT in CWAF 
and in CMWAF, no PPARγ activation was 
observed in any DWAF dilutions tested (see 
Supplemental Material, Figure S1), further 
implicating a COREXIT ingredient and not a 
component of oil as a PPARγ activator. 
CWAF fractionation and analysis. SPE 
was employed to separate CWAF into frac-
tions based on polarity and hydropho-
bicity; CWAF was fractionated into 50:50 
water:ethanol, methanol, DCM, and hexane 
soluble fractions. The PPARγ transactivation 
system demonstrated substantial PPARγ trans-
activation activity in the 50:50 water:ethanol 
fraction, whereas no activity was detected in 
the methanol, DCM (dichloromethane), and 
hexane fractions (Figure 3). The compounds 
present in the CWAF water:ethanol fraction 
were identified using LC-MS and LC-MS/
MS as described in “Materials and Methods.” 
Analysis of the fraction in positive FS mode 
resulted in > 200 unique target masses. 
Tween 80 (polysorbate 80) was concluded 
to be a highly abundant component of this 
fraction based on manual inspection and 
product ion scan profiles (see Supplemental 
Material, Figure S2A). After investiga-
tion of the extract in negative FS mode, 
DOSS was determined to be another 
highly abundant component of the CWAF 
water:ethanol fraction (see Supplemental 
Material, Figure S2B). Mass spectrom-
etry analyses of the transactivation positive 
fraction argued that relatively hydrophilic 
components of COREXIT and not MC252 
oil were responsible for the observed PPARγ 
 transactivation activity.
Modeling of COREXIT components 
binding to PPARγ. Molecular modeling 
was employed to predict which COREXIT 
components might bind to PPARγ. Span 80, 
Tween 80, and DOSS were predicted to 
bind to the PPARγ ligand-binding domain 
as shown by their low E scores, whereas 
propylene glycol and 2-butoxyethanol were 
not (see Supplemental Material, Figure S3A). 
Span 80 and Tween 80 have an ester bond 
that could be cleaved by cellular esterases; 
once cleaved, neither cleavage product is 
predicted to bind tightly (see Supplemental 
Material, Figure S3A). For DOSS docking, 
the basic lysine 367 residue has a strong 
hydrogen bond with a sulfonyl oxygen (see 
Supplemental Material, Figure S3B). The 
α-carbon adjacent to the sulfonyl group of 
DOSS shows potential for strong donation 
to a hydrogen of methionine 364. PPARγ has 
multiple basic residues that allow pairing with 
the acidic sulfhydryl group of DOSS, poten-
tially allowing hydrogen bonding between the 
ligand and receptor. Tween 80, along with 
other compounds that exhibit low E scores, 
either have too large a fatty acid group to 
effectively fit into the binding site of PPARγ 
or have a charge that is too basic, resulting 
in higher binding scores (see Supplemental 
Material, Figure S3A).
PPARγ  transactivation activity of 
COREXIT components .  Collect ively , 
the results above implicate a COREXIT 
component(s) in the PPARγ transactiva-
tion observed in the CWAF prepared from 
MC252 oil. Mass spectrometry indicates 
that Tween 80 and DOSS are present in 
the 50:50 water:ethanol fraction of CWAF, 
which exhibits activity in the transactiva-
tion assay, and molecular modeling predicts 
that Span 80, Tween 80, and DOSS can 
bind to the PPARγ ligand-binding domain. 
Because molecular modeling is speculative, 
these compounds were tested for PPARγ 
activity. Span 80 did not demonstrate PPARγ 
transactivation activity even at concentra-
tions much higher than effective COREXIT 
alone dilutions (see Supplemental Material, 
Figure S4A). Tween 80 had weak activity 
that was much too low to account for the 
activity observed in CWAF and COREXIT 
(see Supplemental Material, Figure S4B). 
Furthermore, a mixture of petroleum distil-
late [ICP (inductively coupled plasma) 
solvent; CAS (Chemical Abstracts Service) 
64742-47-8] and propylene glycol (PG), other 
major components of COREXIT, did not 
demonstrate PPARγ transactivation activity 
(see Supplemental Material, Figure S4C). In 
contrast, a simplified version of COREXIT 
containing only ICP, PG, and DOSS demon-
strated robust PPARγ transactivation (see 
Supplemental Material, Figure S4D). DOSS 
Figure  3. PPARγ transactivation by the 50:50 
ethanol:water CWAF volume fraction. CWAF 
mixtures were fractionated using SPE methods and 
four solvent types to identify fractions containing 
PPARγ ligand-binding activity. PPARγ activity was 
observed only in the 50:50 ethanol:water volume 
fraction but not for methanol, DCM, or hexane frac-
tions. RLU, relative light units. Data are expressed 
as mean ± SD; n = 3 per group (*p < 0.05 vs. no 
treatment control).
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Figure 4. PPARγ transactivation by DOSS. Dilutions 
of mixtures were prepared, HEK293T/17 cells were 
transfected and exposed in triplicate for 18 hr, and 
luciferase activities were measured. Final DOSS 
concentrations (volume fractions) are indicated. 
RLU, relative light units. Data are expressed as 
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Figure 5. PPRE activity in response to DOSS in PPRE-luciferase mice. (A) Representative images of mice 
treated with 10 mg/kg Rosi, vehicle control, or 50 mg/kg DOSS. (B) Luciferase activity of live mice as in 
A. (C) Luciferase assay of liver tissue from mice as in A. RLU, relative light units. Data are expressed as 
mean ± SD; n = 5 per group (*p < 0.05 vs. vehicle control).
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alone elicited dose-dependent increases in 
PPARγ-driven luciferase expression in the 
low ppm range (Figure 4). Thus, DOSS 
has PPARγ transactivation activity, whereas 
Span 80, ICP, and PG do not. Because 
COREXIT 9500 is approximately 10% 
DOSS (Kujawinski et al. 2011), it is likely 
that the PPARγ agonist activity observed 
following treatment with CWAF, CMWAF, 
or COREXIT alone is due to DOSS.
DOSS PPARγ agonist activity in PPRE-
luciferase transgenic mice. To validate the 
PPARγ agonist activity of DOSS, PPRE lucif-
erase reporter mice were used as an in vivo 
model. Male littermates age 5–6 weeks were 
injected with Rosi (positive control), saline 
(negative control), or DOSS. Imaging from 
live mice 5 hr post-treatment revealed marked 
increases in bioluminesence for both Rosi and 
DOSS treatments and suggested that liver 
tissue was the main source of the differential 
luciferase expression, with some expression 
in the skin of Rosi- and DOSS-treated mice 
(Figure 5A). To confirm differential PPRE 
activity in Rosi- and DOSS-treated hepato-
cytes, liver was dissected and homogenized 
immediately following imaging and humane 
sacrifice. As shown, treatment of PPRE-
luciferase mice with 10 mg/kg Rosi increased 
liver luciferase activity approximately 2-fold, 
whereas treatment with 50 mg/kg DOSS 
elicited about a 4-fold increase (Figure 5C), 
demonstrating that DOSS is capable of 
activating PPAR-driven gene expression in 
mice. Although PPARα, a major metabolic 
regulator, is the predominant PPAR isoform 
in the liver, PPARγ is also expressed in hepa-
tocytes. PPRE activation in the liver opened 
the possibility that DOSS may activate 
other PPAR isoforms or RXRα (retinoid X 
receptor alpha). Transactivation assays using 
the human LBDs (ligand-binding domain) 
indicated that 4 ppm DOSS activated PPARγ 
about 3 fold, whereas activation of PPARα 
was only about 1.2 fold and nondetectable for 
the human RXRα LBD (see Supplemental 
Material, Figure S5A,B,D). Of note, DOSS 
activated PPARβ/δ about 8 fold at 4 ppm, 
which is under further investigation (see 
Supplemental Material, Figure S5C).
TR-FRET assays of DOSS affinity for 
PPARγ. The structure of DOSS is shown in 
Figure 6A. The predicted PPARγ receptor-
binding affinities are shown in Supplemental 
Material, Figure S3B. TR-FRET assays were 
used to measure the affinity of DOSS for 
PPARγ. As shown in Figure 6B, DOSS binds 
to the human PPARγ ligand-binding domain 
with a KD of 1,380 nM. This is a binding 
affinity comparable to the pharmaceutical 
PPARγ agonist pioglitazone (KD = 1,310 nM) 
and the endogenous ligand arachidonic acid 
(KD = 1,340 nM), as determined in the same 
assay (Singh et al. 2008).
Adipocyte differentiation in vitro. To 
functionally test the obesogenic potential of 
DOSS, murine 3T3-L1 preadipocytes were 
exposed to low-level adipocyte differen-
tiation inducers with and without DOSS, 
and adipogenesis was quantified by deter-
mining triacylglycerol content (Figure 7A,B). 
Cells were treated with MIM with and 
without DOSS or 1 μM Rosi (positive 
control). Triacylglycerol accumulation was 
quantified using AdipoRed staining (green) 
normalized to cell number (Hoechst nuclear 
counterstaining). Dose-dependent increases in 
adipogenesis were observed with DOSS treat-
ment, with significant differences observed 
at 25 and 50 ppm DOSS (Figure 7A,B). In 
addition, mRNA expression of the preadipo-
cyte marker Pref-1/Dlk1 decreased, whereas 
mRNA expression of the adipocyte marker 
fatty acid binding protein (Fabp4) increased 
dose dependently after 72 hr DOSS treat-
ment (see Supplemental Material, Figure S6). 
These results demonstrate that DOSS 
promotes adipocyte differentiation in vitro.
Figure 7. Adipogenesis following DOSS exposure in vitro. 3T3-L1 cells were grown to confluence over 
72 hr in PGM (preadipocyte growth media). RFU, relative fluorescence units (firefly relative to renilla). Cells 
were either maintained in PGM or treated with MIM (minimal induction media) alone or supplemented 
with 10, 20, 25, or 50 ppm DOSS or 1 μM Rosi for an additional 3 days before analysis. (A) AdipoRed quan-
tification of lipid accumulation as described in “Materials and Methods.” Data are expressed as mean ± 
SD; n = 5 per group (*p < 0.05 vs. MIM control). (B) Representative images of lipid accumulation of cells 
treated as in A (scale bar = 50 μm). 
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Discussion
Increases in general health and longevity 
over the past century are tributes to our 
knowledge of the scientific basis of good 
health. These impressive and hard-won 
gains are now threatened by an obesity 
epidemic (Stewart et al. 2009). Poor nutri-
tion and lifestyle are well-established drivers 
of obesity. Additional contributors might 
include “obesogens,” compounds that alter 
metabolism and fat cell production, as indi-
cated by cell culture and animal model studies 
(Grün and Blumberg 2006; Janesick and 
Blumberg 2011). Maternal–fetal obesogen 
exposure studies in animal models suggest 
that obesogens might exacerbate multiple 
lifelong health issues (Daftary and Taylor 
2006; Janesick and Blumberg 2011; Suzuki 
et al. 2007) and might exacerbate obesity in 
future generations (Li et al. 2012; Tracey et al. 
2013). Still, sound evidence of direct effects 
in humans remains to be determined; it is 
unclear whether environmental obesogens, 
singly or in combination, act through known 
metabolic and/or adipogenic mechanisms 
(e.g., via PPARγ) to cause clinically significant 
outcomes in humans, such as obesity, type 2 
diabetes, insulin resistance syndrome, and 
polycystic ovary syndrome. Obesogens that are 
most prevalent in the environment, including 
those in widely used dispersants, consumables, 
and personal care products would be a good 
focus of such attention.
Here we have identified a novel likely 
obesogen, DOSS, as evidenced by PPARγ 
transactivation activity in a transfected cell line, 
activation of PPRE in transgenic reporter mice, 
and induction of adipogenesis in preadipo-
cytes in vitro. DOSS affinity to human PPARγ 
receptor was also shown to be comparable with 
the pharmaceutical pioglitazone and an endog-
enous ligand arachidonic acid. In addition to 
being a principal component of COREXIT 
oil dispersant used during DWH remedia-
tion, DOSS is also used in many consumer 
goods, including laxatives, household cleaning 
products, deodorants, hair coloring, and 
nail polishes (DHHS 2014; EWG 2015a). 
That DOSS is “generally recognized as safe” 
and is a common additive in flavored drinks 
means that its use may continue to be wide-
spread, creating the likelihood of long-term 
exposures [EWG 2015b; U.S. Food and Drug 
Administration (FDA) 1998]. Significantly, 
DOSS itself (Colace) is prescribed as a laxative 
for pregnant women, in which there is a 38% 
prevalence of constipation, the treatment with 
which could possibly affect fetal development 
(Jewell and Young 2001). Also, fetuses and 
neonates can be at greater risk to food-borne 
contaminants, so groups studying seafood 
contaminant levels suggest that the FDA revise 
the levels of concern for these compounds for 
pregnant women and children (Rotkin-Ellman 
et al. 2012). Although environmentally 
relevant DOSS exposures are not yet known, 
oral laxative use in pregnant women of up 
to 500 mg/day (88.5 kg in an average term 
pregnancy) would be expected to be within an 
order of magnitude of the dose of DOSS used 
in our initial mouse studies, which resulted in 
significant PPRE activity in vivo (Figure 5). 
Clearly, in vivo oral or topical dosing studies 
in animals at doses that are environmentally 
relevant are warranted to fully substantiate and 
understand the direct and long-term impacts 
of such subtoxic level exposures of this likely 
obesogen (Buonsante et al. 2014).
Conclusion
The results of this study indicate that the major 
COREXIT dispersant component DOSS is a 
potential obesogen. This work indicates that 
DOSS might be a compound that negatively 
affects health and that further investigation is 
warranted. The subsequent identification of 
metabolites and biomarkers of DOSS exposure 
and biological consequences of exposure will 
aid in assessing its contribution to obesity and 
related health concerns.
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